EYEFI Signs Strategic Agreement to Expand Sales Activity in New Zealand
TORONTO, ON / ACCESSWIRE / March 26, 2021 / EYEFI Group Technologies Inc. (CSE:EGTI) is…
TORONTO, ON / ACCESSWIRE / March 26, 2021 / EYEFI Group Technologies Inc. (CSE:EGTI) is…
TORONTO, ON / ACCESSWIRE / March 26, 2021 / Adcore Inc. (the “Company” or “Adcore“)…
Seamless EASY Token transfers now activated between Ethereum & Binance Smart Chain TORTOLA, VIRGIN ISLANDS…
VANCOUVER, BC / ACCESSWIRE / March 26, 2021 / Jackpot Digital Inc. (the “Company” or…
DIDCOT, UK / ACCESSWIRE / March 26, 2021 / TR-1: Standard form for notification of major holdings…
AmeraMex to file a Form 12b-25 for a 15-calendar day extension CHICO, CA / ACCESSWIRE…
VANCOUVER, BC / ACCESSWIRE / March 26th, 2021 / LeanLife Health Inc. (CSE:LLP; FSE:LL1, OTCQB:LHLNF)…
ANN ARBOR, MI / ACCESSWIRE / March 26, 2021 / Minerco, Inc. “The Magic Mushroom…
JACKSONVILLE, FL / ACCESSWIRE / March 26, 2021 / GEE Group Inc. (NYSE American:JOB) (“GEE”…
MOSCOW, RUSSIA / ACCESSWIRE / March 26, 2021 / Mechel PAO (MOEX:MTLR, NYSE:MTL), one of…
HOLLYWOOD, CA / ACCESSWIRE / March 26, 2021 / Self-driving cars, solar power, Covid testing,…
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU AS…
Trust Stamp Granted Patent for Identity and Trust Verification Tool ATLANTA, GA / ACCESSWIRE /…
The most exciting image post-production tool on the market is back, and this time, it’s…
Novadiscovery announces new clinical simulation collaboration with Takeda Lyon, France – 26 March, 2021 Novadiscovery…
*** Unofficial English translation – For convenience purposes only *** UCB SA/NV – Public Limited…
CARLSBAD, Calif., March 25, 2021 (GLOBE NEWSWIRE) — Design Therapeutics, Inc., a biotechnology company developing…
BETHESDA, Md., March 25, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (“Gain”) today announced the…
Announced updated STS101 development plan featuring a new Phase 3 efficacy trial scheduled to begin…
IND accepted for VOR33, Vor’s lead eHSC product candidate for treatment of AML Completed initial…